Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy.

Koichi HayanoHiroki WatanabeTakahiro RyuzakiNaoto SawadaGaku OhiraMasayuki KanoMasaya UesatoHisahiro Matsubara

Published in: Surgical case reports (2020)

Conversion surgery might have a survival benefit for HER2 positive stage IV gastric cancer patients. If curative surgery is technically possible, conversion surgery could be a treatment option for HER2 positive stage IV gastric cancer.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
squamous cell carcinoma
epidermal growth factor receptor
coronary artery disease
rectal cancer
locally advanced
prognostic factors
free survival
metastatic breast cancer